Cargando…
Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
A major impediment to the successful use of Taxol in the treatment of cancer is the development of drug resistance. The major cellular target of Taxol is the microtubule that is comprised of α- and β-tubulin heterodimers. Binding sites for Taxol have been delineated on the β-tubulin subunit that has...
Autores principales: | Kavallaris, M, Burkhart, C A, Horwitz, S B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363042/ https://www.ncbi.nlm.nih.gov/pubmed/10362110 http://dx.doi.org/10.1038/sj.bjc.6690507 |
Ejemplares similares
-
Taxol binds to polymerized tubulin in vitro
por: Parness, J, et al.
Publicado: (1981) -
βIII-Tubulin Gene Regulation in Health and Disease
por: Duly, Alastair M. P., et al.
Publicado: (2022) -
Taxol acts differently on different tubulin isotypes
por: Chew, Yean Ming, et al.
Publicado: (2023) -
Respirable antisense oligonucleotides: a new drug class for respiratory disease
por: Tanaka, Makoto, et al.
Publicado: (2001) -
Class III β-tubulin expression and in vitro resistance to microtubule targeting agents
por: Stengel, C, et al.
Publicado: (2010)